GLOBUS MEDICAL, INC. (GMED) FY2026 YTD Q2 P&L / Income Statement

GLOBUS MEDICAL, INC. (GMED) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

1,549,466,000 US dollars

Cost of sales (exclusive of amortization of intangibles)

475,505,000 US dollars

Gross profit (calculated)

1,073,961,000 US dollars

Operating expenses (calculated)

741,141,000 US dollars

Operating income/(loss)

332,820,000 US dollars

Total other income/(expense), net

14,071,000 US dollars

Income/(loss) before income taxes

346,891,000 US dollars

Income tax provision/(benefit)

71,020,000 US dollars

Net income/(loss)

275,871,000 US dollars

Musculoskeletal Solutions

1,496,524,000 US dollars

Enabling Technologies

52,942,000 US dollars

Research and development

72,831,000 US dollars

Selling, general and administrative

584,598,000 US dollars

Amortization of intangibles

59,086,000 US dollars

Acquisition-related costs

17,457,000 US dollars

Restructuring costs

7,169,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.